☆ 4.7 Editorial Material

The Proportion of Donor-Specific Cell-Free DNA in Blood as a Marker of Transplant Rejection: Not an Absolute

CLINICAL CHEMISTRY (2020)

Journal

CLINICAL CHEMISTRY

Volume 66, Issue 10, Pages 1257-1258

Publisher

OXFORD UNIV PRESS INC

DOI: 10.1093/clinchem/hvaa199

Keywords

-

Categories

Medical Laboratory Technology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Immunology

Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation

Yunhui Li, Bin Liang

Summary: This study analyzed the levels of circulating dd-cfDNA in different types of graft rejection and evaluated its diagnostic potential in predicting graft rejection after lung transplantation. The results showed that circulating dd-cfDNA levels were significantly higher in graft rejection, ACR, and AMR compared to non-rejection. Circulating dd-cfDNA could be used as a non-invasive biomarker to distinguish patients with graft rejection from normal stable controls.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Surgery

Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients

Michael B. Keller, Rohan Meda, Sheng Fu, Kai Yu, Moon Kyoo Jang, Ananth Charya, Gerald J. Berry, Charles C. Marboe, Hyesik Kong, Helen Luikart, Ileana L. Ponor, Pali D. Shah, Kiran K. Khush, Steven D. Nathan, Sean Agbor-Enoh

Summary: This study compared plasma dd-cfDNA levels in single and double lung transplant recipients in stable and acute rejection states, finding lower levels in single lung transplant recipients. Adjusting for differences in lung mass eliminated this difference, emphasizing the importance of considering such differences in interpreting dd-cfDNA testing.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Review Immunology

Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions

Ashish Kataria, Dhiren Kumar, Gaurav Gupta

Summary: Recent years have seen significant growth in clinical research on the use of donor-derived cell-free DNA (dd-cfDNA) in solid-organ transplants (SOT). While initially studied as a means of detecting allograft rejection, it is now considered more of an indicator of the severity of organ damage. Multiple studies suggest that dd-cfDNA is effective in diagnosing antibody-mediated rejection but less so for T-cell-mediated rejection.

TRANSPLANTATION (2021)

Add to Collection

Review Immunology

Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions

Ashish Kataria, Dhiren Kumar, Gaurav Gupta

Summary: Recent years have seen a surge in clinical research on the use of donor-derived cell-free DNA (dd-cfDNA) in solid-organ transplants, showing potential in diagnosing rejection reactions. While most studies have focused on kidney transplants, research on other organ transplants is ongoing. Findings indicate that dd-cfDNA can serve as a marker for assessing injury severity, but its specificity in relation to rejection reactions requires further exploration.

TRANSPLANTATION (2021)

Add to Collection

Article Urology & Nephrology

The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies

Philip F. Halloran, Jeff Reeve, Katelynn S. Madill-Thomsen, Zachary Demko, Adam Prewett, Paul Billings, Trifecta Investigators

Summary: The donor-derived cell-free DNA fraction (dd-cfDNA[%]) in plasma at the time of indication biopsy is strongly correlated with gene expression in the biopsied allograft, particularly in cases of active molecular rejection. This correlation has the potential to reduce unnecessary biopsies in kidney transplant recipients.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Add to Collection

Article Immunology

Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological Findings

Elisabet Van Loon, Baptiste Lamarthee, Thomas Barba, Sandra Claes, Maarten Coemans, Henriette de Loor, Marie-Paule Emonds, Priyanka Koshy, Dirk Kuypers, Paul Proost, Aleksandar Senev, Ben Sprangers, Claire Tinel, Olivier Thaunat, Amaryllis H. Van Craenenbroeck, Dominique Schols, Maarten Naesens

Summary: Through multiplex assay, we found that kidney transplant patients with donor-specific anti-human leukocyte antigen antibodies and histological rejection have increased levels of pro-inflammatory cytokines in blood. Even in patients without histological rejection, elevated pro-inflammatory cytokine levels can be observed. These findings challenge the concept of histology as the gold standard for identifying ongoing allo-immune activation after transplantation.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation

Bogdan Obrisca, Maria Butiu, Lena Sibulesky, Ramasamy Bakthavatsalam, Kelly D. Smith, Idoia Gimferrer, Paul Warner, Gener Ismail, Nicolae Leca

Summary: This study investigated the factors influencing dd-cfDNA levels in kidney transplant recipients, revealing that dnDSA was the independent determinant of dd-cfDNA levels, and dd-cfDNA showed good diagnostic value in discriminating rejection and antibody-mediated rejection.

SCIENTIFIC REPORTS (2022)

Add to Collection

Editorial Material Urology & Nephrology

Donor-derived cell-free DNA in kidney transplantation: evolving concepts and potential limitations

Edmund Huang, Stanley C. Jordan

Summary: The study suggests that elevated donor-derived cell-free DNA detected on serial measurements can serve as an important indicator for monitoring kidney allograft health, predicting rejection, future de novo donor-specific antibodies, and decline in estimated glomerular filtration rate.

KIDNEY INTERNATIONAL (2022)

Add to Collection

Article Multidisciplinary Sciences

Comparison of long-term outcomes in simultaneous pancreas-kidney transplant versus simultaneous deceased donor pancreas and living donor kidney transplant

Jin-Myung Kim, Youngmin Ko, Minha Choi, Hye Eun Kwon, Jae Jun Lee, Joo Hee Jung, Hyunwook Kwon, Young Hoon Kim, Sung Shin

Summary: Simultaneous deceased donor pancreas and living donor kidney transplant (SPLK) offers advantages over conventional simultaneous pancreas-kidney transplant (SPK) and can help address the shortage of organs for diabetic patients. A comparison of clinical outcomes between SPK and SPLK showed no significant differences in baseline characteristics except for certain factors. SPLK had lower pancreas graft survival rate and higher incidence of pancreas graft rejection. However, there were no significant differences in de novo DSA presence, kidney graft failure, kidney graft rejection, and mortality rates.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Immunology

Progressive Loss of Donor-Reactive CD4+Effector Memory T Cells due to Apoptosis Underlies Donor-Specific Hyporesponsiveness in Stable Renal Transplant Recipients

Amy C. J. van der List, Nicolle H. R. Litjens, Mariska Klepper, Frederique Prevoo, Michiel G. H. Betjes

Summary: This study investigates the characteristics of DSH, a lowered response of alloreactive T cells after kidney transplantation. The results show a decline in donor-reactive CD4+ T cells within the first 3-5 years after transplantation, mainly affecting effector memory T cells capable of producing proinflammatory cytokines. This decline is strongly correlated with reduced proliferation of CD4+ T cells to donor Ag.

JOURNAL OF IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study

Philip F. Halloran, Jeff Reeve, Katelynn S. Madill-Thomsen, Zachary Demko, Adam Prewett, Philippe Gauthier, Paul Billings, Christopher Lawrence, Dave Lowe, Luis G. Hidalgo

Summary: This study analyzed the triple results of 280 kidney transplant biopsies, focusing on the question of dd-cfDNA levels in DSA-negative antibody-mediated rejection (AMR). The findings showed that DSA-negative AMR had moderately decreased AMR-associated features compared with DSA-positive AMR, but similarly elevated dd-cfDNA levels. Therefore, dd-cfDNA is superior to DSA in predicting AMR in this population, but the optimal predictions require both dd-cfDNA and DSA.

TRANSPLANTATION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study

Moon Kyoo Jang, Ilker Tunc, Gerald J. Berry, Charles Marboe, Hyesik Kong, Michael B. Keller, Pali D. Shah, Irina Timofte, Anne W. Brown, Ileana L. Ponor, Cedric Mutebi, Mary C. Philogene, Kai Yu, Aldo Iacono, Jonathan B. Orens, Steven D. Nathan, Sean Agbor-Enoh

Summary: This study demonstrates that %ddcfDNA reliably detects acute rejection and other clinical complications potentially missed by histopathology, lending support to its use as a non-invasive marker of allograft injury.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

Add to Collection

Article Transplantation

Predictors of graft failure after first detection of de novo donor-specific HLA antibodies in kidney transplant recipients

Covadonga Lopez del Moral, Kaiyin Wu, Marcel Naik, Bilgin Osmanodja, Aylin Akifova, Nils Lachmann, Diana Stauch, Sabine Hergovits, Mira Choi, Friederike Bachmann, Fabian Halleck, Eva Schrezenmeier, Danilo Schmidt, Klemens Budde

Summary: This study found that renal function, proteinuria, and rejection are strongly associated with graft failure in patients with dnDSAs and may serve as surrogate endpoints.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Add to Collection

Article Urology & Nephrology

Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation

Christophe Masset, Gabriela Gautier-Vargas, Diego Cantarovich, Simon Ville, Jacques Dantal, Florent Delbos, Alexandre Walencik, Clarisse Kerleau, Maryvonne Hourmant, Claire Garandeau, Aurelie Meurette, Magali Giral, Ilies Benotmane, Sophie Caillard, Gilles Blancho

Summary: Decreased immunosuppression in kidney transplant recipients infected with COVID-19 has a limited impact on the alloreactive immune response and rejection episodes. The incidence of post-COVID-19 DSA is low and mainly occurs in high-risk immunologic patients. COVID-19 severity is not associated with post-COVID-19 DSA and rejection episodes.

KIDNEY INTERNATIONAL REPORTS (2022)

Add to Collection

Article Urology & Nephrology

Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection

Katelynn S. Madill-Thomsen, Georg A. Boehmig, Jonathan Bromberg, Gunilla Einecke, Farsad Eskandary, Gaurav Gupta, Luis G. Hidalgo, Marek Myslak, Ondrej Viklicky, Agnieszka Perkowska-Ptasinska, Philip F. Halloran

Summary: The study found that in kidney transplant patients classified as having no rejection, there are subtle increases in antibody-mediated rejection-related transcripts in biopsies that are positive for DSA. As the frequency of DSA increases, there is a gradient of increasing molecular ABMR-like transcript expression in these biopsies.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Uncovering transcriptional dark matter via gene annotation independent single-cell RNA sequencing analysis

Michael F. Z. Wang, Madhav Mantri, Shao-Pei Chou, Gaetano J. Scuderi, David W. McKellar, Jonathan T. Butcher, Charles G. Danko, Iwijn De Vlaminck

Summary: Conventional single-cell RNA sequencing analysis relies on genome annotations that may be incomplete or inaccurate especially for understudied organisms. Here the authors present a bioinformatic tool that leverages single-cell data to uncover biologically relevant transcripts beyond the best available genome annotation.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Spatiotemporal single-cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis

Madhav Mantri, Gaetano J. Scuderi, Roozbeh Abedini-Nassab, Michael F. Z. Wang, David McKellar, Hao Shi, Benjamin Grodner, Jonathan T. Butcher, Iwijn De Vlaminck

Summary: By utilizing single-cell and spatial transcriptomics in chicken hearts, the authors conducted a census of cellular interactions from early to late four-chambered heart stage, identifying a distinct epicardial-mesenchymal cell population with a migratory phenotype.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Medical Laboratory Technology

Measurement Biases Distort Cell-Free DNA Fragmentation Profiles and Define the Sensitivity of Metagenomic Cell-Free DNA Sequencing Assays

Adrienne Chang, Omary Mzava, Joan S. Lenz, Alexandre P. Cheng, Philip Burnham, S. Timothy Motley, Crissa Bennett, John T. Connelly, Darshana M. Dadhania, Manikkam Suthanthiran, John R. Lee, Amy Steadman, Iwijn De Vlaminck

Summary: The choice of DNA isolation and library preparation methods has a significant impact on the sensitivity of metagenomic cfDNA sequencing, and the bias in fragment length distributions from different experimental procedures plays an important role in the sensitivity of metagenomic cfDNA sequencing. Standardization in sample preparation protocols is crucial for achieving substantial gains in the sensitivity of microbial and other short fragment recovery in liquid biopsy.

CLINICAL CHEMISTRY (2022)

Add to Collection

Editorial Material Medical Laboratory Technology

Molecular Approaches to Transplant Monitoring; Is the Horizon Here?

Sean Agbor-Enoh, Michael Oellerich, Angela Wu, Philip F. Halloran, Iwijn De Vlaminck, Michael Keller

CLINICAL CHEMISTRY (2021)

Add to Collection

Article Multidisciplinary Sciences

Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation

Alexandre Pellan Cheng, Matthew Pellan Cheng, Conor James Loy, Joan Sesing Lenz, Kaiwen Chen, Sami Smalling, Philip Burnham, Kaitlyn Marie Timblin, Jose Luis Orejas, Emily Silverman, Paz Polak, Francisco M. Marty, Jerome Ritz, Iwijn De Vlaminck

Summary: Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for hematologic malignancies and immune disorders. This study shows that cell-free DNA (cfDNA) in blood can be used for monitoring posttransplant complications, including graft-versus-host disease (GVHD), infection, relapse of underlying disease, and graft failure. The study demonstrates the potential of cfDNA to improve the care of HCT recipients by enabling earlier detection and better prediction of these complications.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Biology

Large-scale integration of single-cell transcriptomic data captures transitional progenitor states in mouse skeletal muscle regeneration

David W. McKellar, Lauren D. Walter, Leo T. Song, Madhav Mantri, Michael F. Z. Wang, Iwijn De Vlaminck, Benjamin D. Cosgrove

Summary: The study integrates single-cell and -nuclear transcriptomic analyses of mouse skeletal muscle in different conditions and after injury, constructing a transcriptomic model of myogenesis that identifies rare transitional states and cell subtypes. This resource supports large-scale integration of single-cell transcriptomic data for biological discovery.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

A metagenomic DNA sequencing assay that is robust against environmental DNA contamination

Omary Mzava, Alexandre Pellan Cheng, Adrienne Chang, Sami Smalling, Liz-Audrey Djomnang Kounatse, Joan Sesing Lenz, Randy Longman, Amy Steadman, Luis G. Gomez-Escobar, Edward J. Schenck, Mirella Salvatore, Michael J. Satlin, Manikkam Suthanthiran, John R. Lee, Christopher E. Mason, Darshana Dadhania, Iwijn De Vlaminck

Summary: SIFT-seq is a robust metagenomic DNA sequencing assay that allows for the identification and removal of environmental DNA contamination introduced during sample preparation. It has been successfully applied in screening for low-burden microbial infections in blood and urine, identifying COVID-19 co-infections, characterizing the urinary microbiome, and identifying microbial DNA signatures of sepsis and inflammatory bowel disease in blood.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Multidisciplinary Sciences

A Tead1-Apelin axis directs paracrine communication from myogenic to endothelial cells in skeletal muscle

Umji Lee, Pascal Stuelsatz, Sonia Karaz, David W. McKellar, Julie Russeil, Maria Deak, Iwijn De Vlaminck, Christoph Lepper, Bart Deplancke, Benjamin D. Cosgrove, Jerome N. Feige

Summary: This study identifies the regulation of Apelin by Tead1, with Tead1 playing an important role in myogenic cells and influencing Apln secretion, which in turn affects endothelial remodeling during muscle repair.

ISCIENCE (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Spatial mapping of the total transcriptome by in situ polyadenylation

David W. McKellar, Madhav Mantri, Meleana M. Hinchman, John S. L. Parker, Praveen Sethupathy, Benjamin D. Cosgrove, Iwijn De Vlaminck

Summary: Spatial transcriptomics allows us to study the spatial context of gene expression. Current methods are limited to detecting a subset of RNA transcripts. By using enzymatic in situ polyadenylation of RNA, we are able to detect the full spectrum of RNAs, expanding the scope of research. Applying this approach, we studied skeletal muscle regeneration and viral-induced myocarditis, and made new discoveries.

NATURE BIOTECHNOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosis

Adrienne Chang, Omary Mzava, Liz-Audrey Kounatse Djomnang, Joan Sesing Lenz, Philip Burnham, Peter Kaplinsky, Alfred Andama, John Connelly, Christine M. Bachman, Adithya Cattamanchi, Amy Steadman, Iwijn De Vlaminck

Summary: Metagenomic next-generation sequencing has the potential for tuberculosis diagnosis, but the diagnostic performance is influenced by the composition of the control population and the burden of nontuberculous mycobacterial DNA.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Spatial total RNA-sequencing maps coding, noncoding and viral RNAs in tissues

David W. McKellar, Iwijn De Vlaminck

Summary: Spatial total RNA-sequencing (STRS) combines in situ polyadenylation with existing spatial transcriptomics technologies, providing a comprehensive view of the transcriptome in tissues. This technique was used to spatially map coding, noncoding and nonhost RNAs in skeletal muscle regeneration and viral myocarditis models.

NATURE BIOTECHNOLOGY (2023)

Add to Collection

Article Urology & Nephrology

Peritoneal Effluent Cell-Free DNA Sequencing in Peritoneal Dialysis Patients With and Without Peritonitis

Philip Burnham, Fanny Chen, Alexandre P. Cheng, Vesh Srivatana, Lisa T. Zhang, Emmanuel Edusei, Shady Albakry, Brittany Botticelli, Xunxi Guo, Amanda Renaghan, Jeffrey Silberzweig, Darshana M. Dadhania, Joan S. Lenz, Michael Heyang, Iliyan D. Iliev, Joshua A. Hayden, Lars F. Westblade, Iwijn De Vlaminck, John R. Lee

Summary: This study examines the utility of metagenomic sequencing of peritoneal effluent cell-free DNA (cfDNA) for evaluating the peritoneal effluent in PD patients with and without peritonitis. The results show that metagenomic sequencing can detect and identify various pathogens in the peritoneal effluent of PD patients, including cases of culture-negative peritonitis.

KIDNEY MEDICINE (2022)

Add to Collection

Article Engineering, Biomedical

Recent advances in tools to map the microbiome

Hao Shi, Benjamin Grodner, Iwijn De Vlaminck

Summary: Microbes thrive in diverse habitats, forming ecological niches with rich species diversity and complex spatial structure. Mapping microbial genes, transcripts, and metabolites spatially can provide a better understanding of microbiome structure and function, with significant implications for future microbiome research.

CURRENT OPINION IN BIOMEDICAL ENGINEERING (2021)

Add to Collection

Article Medicine, Research & Experimental

Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity

Alexandre Pellan Cheng, Matthew Pellan Cheng, Wei Gu, Joan Sesing Lenz, Elaine Hsu, Erwin Schurr, Guillaume Bourque, Mathieu Bourgey, Jerome Ritz, Francisco M. Marty, Charles Y. Chiu, Donald C. Vinh, Iwijn De Vlaminck

Summary: The study developed a blood test to quantify cell-, tissue-, and organ-specific injury due to COVID-19, finding evidence of lung and liver injury and involvement of red blood cell progenitors. The concentration of cell-free DNA correlated with disease progression and was significantly increased in patients requiring intubation, suggesting the utility of cell-free DNA as an analyte for monitoring and studying COVID-19.

MED (2021)

Add to Collection

Article Respiratory System

Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation

Kiran K. Khush, Iwijn De Vlaminck, Helen Luikart, David J. Ross, Mark R. Nicolls

Summary: This study measured dd-cfDNA in lung transplantation recipients, finding elevated levels in cases of acute cellular rejection and chronic lung allograft dysfunction. There was no significant difference in dd-cfDNA levels for antibody-mediated rejection and allograft infection compared to stable cases. A threshold of 0.85% for dd-cfDNA was determined as optimal for predicting rejection events with moderate sensitivity and specificity.

ERJ OPEN RESEARCH (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.